Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1o Prevent the Tumor Recurrence for Hepatocellular Carcinoma After Liver Transplantation: A Randomized Controlled Study
Status: Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 26 Apr 2017
Price : $35 *
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 10 Aug 2015 Planned initiation date changed from 1 Jun 2014 to 1 Jul 2015, as reported by ClinicalTrials.gov.
- 07 Jul 2014 Planned primary completion date changed to 1 Jun 2017.
- 07 Jul 2014 New trial record